Cardiovascular Assessment and Treatment During COPD Exacerbation to Improve Diagnosis and Outcomes
Early Cardiovascular Risk Assessment of Patients With COPD During Respiratory Exacerbation for the Identification and Treatment of Cardiovascular Comorbidity
Tel-Aviv Sourasky Medical Center
150 participants
Mar 1, 2025
INTERVENTIONAL
Conditions
Summary
This is a research study involving patients hospitalized for COPD flare-ups. Patients will be randomly assigned to two groups: one group will only see a pulmonologist (lung doctor), and the other group will also be seen by a cardiologist (heart doctor) during their hospital stay. Both groups will fill out a questionnaire, and the pulmonologist will review their lung disease, adjust their treatment, and recommend follow-up care. The cardiologist will also assess the second group for heart diseases (like high cholesterol, diabetes, heart disease, high blood pressure, or heart failure) and start or adjust heart treatment if needed. Both groups will be followed up by phone 1, 3, 6 and 12 months later to check for changes in treatment, new heart problems, COPD flare-ups, or death.
Eligibility
Inclusion Criteria3
- Documented COPD (based on lung function tests, symptoms and relevant treatment).
- Aged 18-75 years.
- Mentally competent to understand and follow medical recommendations.
Exclusion Criteria3
- Under 18 years of age.
- Unable to provide consent.
- Unstable concurrent disease.
Interventions
The cardiology consultation will include the following: a structured interview (see Appendix A), physical examination, review of laboratory tests including HbA1c, lipid profile, BNP, ECG, and POCUS (point-of-care ultrasound) to assess heart contraction and valve function.
optimize basic treatment, and recommend continued follow-up as needed.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06723795